Related Experiment Videos
Genetics and cardiomyopathy: where are we now?
Ross T Murphy1, Randall C Starling
1Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, OH 44195, USA.
Cleveland Clinic Journal of Medicine
|July 16, 2005
Summary
Genetic factors significantly contribute to cardiomyopathies like hypertrophic cardiomyopathy and dilated cardiomyopathy. Clinical genetic testing is emerging, impacting patient care and diagnosis.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Cardiomyopathies, including hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), frequently have a genetic basis.
- Genetic factors account for up to 90% of familial HCM cases and 30-50% of DCM cases.
- Advances in genetic research are uncovering the molecular underpinnings of these heart muscle diseases.
Purpose of the Study:
- To review the discovery of genetic factors in cardiomyopathy.
- To explain the implications of genetic discoveries for clinical practice.
- To provide an overview of emerging clinical genetic testing for HCM.
Main Methods:
- Review of scientific literature on genetic studies in cardiomyopathy.
- Analysis of the impact of genetic findings on diagnostic approaches.
- Discussion of the integration of genetic testing into clinical workflows.
Main Results:
- Identification of numerous genes associated with HCM and DCM.
- Demonstration of the heritability of cardiomyopathies.
- Development and increasing availability of clinical genetic testing for HCM.
Conclusions:
- Genetic insights are revolutionizing the understanding and management of cardiomyopathies.
- Clinical genetic testing for HCM offers new diagnostic and prognostic possibilities.
- Future clinical practice will increasingly incorporate genetic information for personalized cardiomyopathy care.